Skip to main content
. 2016 Apr 22;95(16):e3417. doi: 10.1097/MD.0000000000003417

FIGURE 3.

FIGURE 3

Infliximab levels. Circulating infliximab (IFX) trough levels measured by functional reporter gene assay (RGA) in patients with IFX treatment failure due to nonimmune pharmacokinetics (PK) (n = 18) or pharmacodynamics (PD) (n = 8) at time of treatment failure (week 0) and after 12 weeks of intensified IFX regimen.